CXCR4-modification enhances CAR-T efficacy by improving tumor tracking and bone marrow homing in B-cell malignancies

Key Points

• Improved tumor tracking and bone marrow homing enhances CAR-T efficacy in B-cell malignancies.
• CXCR4-modified CAR-T cells showed a significant increase in targeting accuracy within tumors.
• The method utilized advanced genetic engineering for CAR-T cell modification to express CXCR4.
• Overall, findings may facilitate better treatment options for patients with B-cell malignancies.